Unlocking the potential of cancer immune-cell therapies Cancer immune-cell therapy using iPS-Ts has the potential to become a curative intervention for the treatment not only of myeloproliferative ...

“My greater criticism is that I just don't think customized cell therapy will be possible or cost effective on a large scale,” Colman says. “I still think of iPS cells as 'the concept car ...

A German medical team has developed and tested a possible treatment for people with severe heart failure that could ...

Innovative muscle patches derived from stem cells demonstrate efficacy in heart repair, improving function in primates and a ...

Implanted patches of iPS cell-derived heart muscle integrated with heart tissue in a primate model of heart failure, and in patients being treated in a clinical trial, marks progress toward a ...

Our lab uses human iPS and ES cells for modeling human disorders of the brain and peripheral nervous system such as Parkinson’s disease, familial dysautonomia, Herpes Simplex encephalitis and ...

Ips Heart Inc. has been awarded orphan drug designation by the FDA for its GIVI-MPC stem cell therapy for Becker muscular dystrophy. GIVI-MPC has the unique ability to create new muscle with full ...

Efforts to use iPS cells to develop powerful new treatments ... Japan, in particular, has lagged in the field of gene therapy, a medical approach that treats or prevents disease by correcting ...

“I believe that iPS cells can be used to treat other eye ... This could change through CAR T-cell therapy, the groundbreaking method of reengineering a patient’s immune cells.

This involves a new stem cell therapy that uses genetically reprogrammed stem cells called iPS cells. 00:22 Professor Shinya Yamanaka was awarded the Nobel Prize in 2012 for his development of iPS ...

View Full Profile. Learn about our Editorial Policies. To create the therapy, researchers reprogrammed skin cells from an anonymous donor into induced pluripotent stem cells (iPSCs), then ...